Ge Long Hui A P P·2026-02-24 08:35Core Viewpoint - Sanofi Health (688336.SH) reported a significant increase in its 2025 annual performance, with total revenue reaching 4.199 billion yuan, a year-on-year increase of 251.81%, and a net profit attributable to shareholders of 2.939 billion yuan, up 317.09% [1] Financial Performance - The company achieved a net profit of 2.905 billion yuan after excluding non-recurring gains and losses, reflecting a staggering growth of 1041.01% [1] - Total assets at the end of the reporting period amounted to 8.887 billion yuan, an increase of 48.99% from the beginning of the year [1] - Shareholders' equity attributable to the parent company reached 8.457 billion yuan, growing by 51.89% compared to the start of the year [1] Revenue Drivers - The substantial growth in revenue and profit was primarily driven by a significant collaboration with Pfizer Inc., which included a licensing fee payment of approximately 2.890 billion yuan related to Project 707 [1]